30 Years of Groundbreaking Science, Training, and Innovation

Satellite Programs

The New Frontier: Can We Finally Predict and Start Treating Vulnerable Plaque?

Presentation Theater Program

09/24/2018 11:30:00 09/24/2018 12:30:00 The New Frontier: Can We Finally Predict and Start Treating Vulnerable Plaque? TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Presentation Theater Program

Monday, September 24, 2018
Program: 11:30 am-12:30 pm
San Diego Convention Center, Presentation Theater 5

The New Frontier: Can We Finally Predict and Start Treating Vulnerable Plaque?

The New Frontier: Can We Finally Predict and Start Treating Vulnerable Plaque?

Sponsored by InfraReDx, Inc.

Chair  

Ron Waksman, MD, FACC

MedStar Heart and Vascular Institute

Washington, DC

Faculty  

David Erlinge, MD

Skane University Hospital

Lund, Sweden

 

John McB. Hodgson

MetroHealth Medical Center

Cleveland, Ohio

 

Ryan D. Madder, MD

Frederik Meijer Heart & Vascular Institute, Spectrum Health

Grand Rapids, MI

 

James E. Muller, MD

Brigham and Women's Hospital

Boston, MA

 

Jonathan Tobis, MD

UCLA

Los Angeles, CA

 

Robert L. Wilensky, MD

Hospital of the University of Pennsylvania

Philadelphia, PA

Agenda

11:30 am

Introduction

Moderator : Ron Waksman

11:35 am

IVUS+NIRS Technology Overview and Early Clinical Trials

Ryan D. Madder

11:43 am

Current Clinical Uses of IVUS+NIRS

John McB. Hodgson

11:51 am

Ongoing Clinical trials and Future Treatment Strategies for Vulnerable Plaque

David Erlinge

11:59 am

New Applications of NIRS: Collagen Deficient Cap Detection

Robert L. Wilensky

12:07 pm

LRP Study Results & Impact on Your Practice

Ron Waksman

12:15 pm

Panel Discussion and Q&A

Moderator : Ron Waksman

Discussants : John McB. Hodgson, James E. Muller, Jonathan Tobis, Robert L. Wilensky

12:30 pm

Adjourn